News + Filings Transactions
|
Forrester Robert
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/03/2019 | Verastem, Inc. | VSTM | Grant | Stock Option (Right to Buy) | 240k | $3.51 | $842.4k | | 01/03/2019 |
| 09/28/2018 | Verastem, Inc. | VSTM | Purchase | Common Stock | 2k | $7.00 | $14k | | 09/24/2018 |
| 09/27/2018 | Verastem, Inc. | VSTM | Purchase | Common Stock | 500 | $7.00 | $3.5k | | 09/27/2018 |
| 09/27/2018 | Verastem, Inc. | VSTM | Purchase | Common Stock | 10k | $7.00 | $70k | | 09/27/2018 |
| 09/24/2018 | Verastem, Inc. | VSTM | Grant | Stock Option (Right to Buy) | 60k | $2.97 | $178.2k | | 09/24/2018 |
| 04/06/2018 | Verastem, Inc. | VSTM | Grant | Stock Option (Right to Buy) | 30k | $2.97 | $89.1k | | 04/06/2018 |
| 01/05/2018 | Verastem, Inc. | VSTM | Grant | Stock Option (Right to Buy) | 150k | $2.97 | $445.5k | | 01/05/2018 |
| 09/19/2017 | Verastem, Inc. | VSTM | Grant | Stock Option (Right to Buy) | 50k | $1.37 | $68.5k | | 09/19/2017 |
| 01/09/2017 | Verastem, Inc. | VSTM | Grant | Stock Option (Right to Buy) | 360k | $1.20 | $432k | | 01/09/2017 |
| 10/29/2016 | Verastem, Inc. | VSTM | Grant | Stock Option (Right to Buy) | 50k | $1.37 | $68.5k | | 10/29/2015 |
| 01/01/2016 | Verastem, Inc. | VSTM | Grant | Stock Option (right to buy) | 132k | $1.86 | $245.5k | | 01/01/2016 |
| 11/09/2015 | Verastem, Inc. | VSTM | Grant | Stock Option (right to buy) | 268k | $2.13 | $570.8k | | 11/09/2015 |
| 08/01/2015 | Verastem, Inc. | VSTM | Payment of Exercise | Common Stock | 8.2k | $7.30 | $59.8k | | 08/01/2015 |
| 06/29/2015 | Verastem, Inc. | VSTM | Purchase | Common Stock | 2k | $7.11 | $14.2k | | 06/29/2015 |
| 06/17/2015 | Verastem, Inc. | VSTM | Purchase | Common Stock | 1000 | $7.97 | $8k | | 06/17/2015 |
| 02/01/2015 | Verastem, Inc. | VSTM | Payment of Exercise | Common Stock | 8.2k | $7.30 | $59.8k | | 02/01/2015 |
| 01/08/2015 | Verastem, Inc. | VSTM | Grant | Stock Option (Right to Buy) | 270.5k | $9.19 | $2.5M | | 01/08/2015 |
| 12/19/2014 | Verastem, Inc. | VSTM | Purchase | Common Stock | 1000 | $8.66 | $8.7k | | 12/19/2014 |
| 08/01/2014 | Verastem, Inc. | VSTM | Payment of Exercise | Common Stock | 8.2k | $7.39 | $60.6k | | 08/01/2014 |
| 05/13/2014 | Verastem, Inc. | VSTM | Purchase | Common Stock | 1000 | $7.62 | $7.6k | | 05/13/2014 |
| 02/04/2014 | Verastem, Inc. | VSTM | Payment of Exercise | Common Stock | 8.3k | $12.56 | $104.2k | | 02/04/2014 |
| 01/07/2014 | Verastem, Inc. | VSTM | Grant | Stock Option (Right to Buy) | 250k | $13.59 | $3.4M | | 01/07/2014 |
| 09/17/2013 | Verastem, Inc. | VSTM | Grant | Stock Option (Right to Buy) | 50k | $14.18 | $709k | | 09/17/2013 |
| 08/01/2013 | Verastem, Inc. | VSTM | Payment of Exercise | Common Stock | 8.4k | $15.19 | $127k | | 08/01/2013 |
| 06/13/2013 | Verastem, Inc. | VSTM | Purchase | Common Stock | 1000 | $11.39 | $11.4k | | 06/13/2013 |
| 03/12/2013 | Verastem, Inc. | VSTM | Payment of Exercise | Common Stock | 16.9k | $9.37 | $158.2k | | 03/12/2013 |
| 01/15/2013 | Verastem, Inc. | VSTM | Grant | Stock Option (Right to Buy) | 250k | $9.85 | $2.5M | | 01/15/2013 |
| 02/01/2012 | Verastem, Inc. | VSTM | Grant | Common Stock | 142.9k | $0.00 | $0 | | 02/01/2012 |
| 11/11/2010 | Myrexis, Inc. | MYRX | Grant | Director Stock Option (Right to Buy) | 16.2k | $3.71 | $60.3k | | 11/11/2010 |
| 12/21/2009 | EPIRUS Biopharmaceuticals, Inc. | EPRS | Disposition | Non-Qualified Stock Option (right to buy) | 25k | $6.47 | $161.8k | | 12/21/2009 |
| 12/21/2009 | EPIRUS Biopharmaceuticals, Inc. | EPRS | Grant | Non-Qualified Stock Option (right to buy) | 15.6k | $1.07 | $16.7k | | 12/21/2009 |
| 12/21/2009 | EPIRUS Biopharmaceuticals, Inc. | EPRS | Disposition | Non-Qualified Stock Option (right to buy) | 150k | $4.57 | $685.5k | | 12/21/2009 |
| 12/21/2009 | EPIRUS Biopharmaceuticals, Inc. | EPRS | Grant | Non-Qualified Stock Option (right to buy) | 115.4k | $1.07 | $123.5k | | 12/21/2009 |
| 12/21/2009 | EPIRUS Biopharmaceuticals, Inc. | EPRS | Disposition | Non-Qualified Stock Option (right to buy) | 87.5k | $3.43 | $300.1k | | 12/21/2009 |
| 12/21/2009 | EPIRUS Biopharmaceuticals, Inc. | EPRS | Grant | Non-Qualified Stock Option (right to buy) | 67.3k | $1.07 | $72k | | 12/21/2009 |
|
|